EVIDENSIA DYREHOSPITAL A/S

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  6.2% 3.8% 1.9% 0.5% 0.7%  
Credit score (0-100)  39 51 68 99 92  
Credit rating  BB BB BBB AA A  
Credit limit (kDKK)  -0.0 0.0 36.5 14,983.9 12,496.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Gross profit  72,214 72,972 80,941 77,186 64,187  
EBITDA  3,772 6,009 16,288 20,608 10,766  
EBIT  3,772 6,009 16,288 6,449 -3,874  
Pre-tax profit (PTP)  -4,610.0 -1,147.0 12,310.0 8,539.3 -2,554.4  
Net earnings  -4,610.0 -1,147.0 12,310.0 6,653.5 -2,044.3  
Pre-tax profit without non-rec. items  3,772 6,009 16,288 8,539 -2,554  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Tangible assets total  0.0 0.0 0.0 26,351 34,079  
Shareholders equity total  -21,119 103,420 115,730 122,384 120,339  
Interest-bearing liabilities  0.0 0.0 0.0 2,123 2,407  
Balance sheet total (assets)  116,203 127,414 138,864 138,708 147,089  

Net Debt  0.0 0.0 0.0 -17,160 -12,185  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  72,214 72,972 80,941 77,186 64,187  
Gross profit growth  22.4% 1.0% 10.9% -4.6% -16.8%  
Employees  115 113 122 130 121  
Employee growth %  0.0% -1.7% 8.0% 6.6% -6.9%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  116,203 127,414 138,864 138,708 147,089  
Balance sheet change%  -17.2% 9.6% 9.0% -0.1% 6.0%  
Added value  3,772.0 6,009.0 16,288.0 6,449.2 10,765.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 43,997 -17,971  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 -1.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  5.2% 8.2% 20.1% 8.4% -6.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  2.7% 4.5% 12.2% 6.4% -0.8%  
ROI %  2.7% 4.5% 12.2% 6.6% -0.9%  
ROE %  -965.4% -2.8% 11.2% 5.6% -1.7%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  0.0% 100.0% 97.3% 88.2% 81.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -83.3% -113.2%  
Gearing %  0.0% 0.0% 0.0% 1.7% 2.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 31.5% 59.3%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.0 0.0 0.0 8.4 4.9  
Current Ratio  0.0 0.0 0.0 8.9 5.2  
Cash and cash equivalent  0.0 0.0 0.0 19,283.3 14,591.8  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 71,397.1 69,774.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  33 53 134 50 89  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  33 53 134 159 89  
EBIT / employee  33 53 134 50 -32  
Net earnings / employee  -40 -10 101 51 -17